MyFinsight
Home
Blog
About
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$6,881,088
Free Cash flow
-$924,992
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from public offering
Exercise of warrants
Inventory
Others
Negative Cash Flow Breakdown
Net (loss)
Deposits
Accounts payable & accrued expen...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents at beginning of period
-
-
-
9,686,529
Net (loss)
-1,564,048
-1,243,869
-2,140,927
-883,820
Depreciation and amortization
77,974
76,859
98,581
96,163
Intangible assets impairment
-
-
131,788
554,650
Disposal of tangible assets
-
-
7
10,250
Intangible asset impairment
0
-
-
-
Stock issued for services
96,900
-
0
0
Accounts receivable
88,610
609,601
-41,293
649,850
Inventory
-793,996
-78,399
-772,796
1,286,164
Deposits
209,740
71,740
-
-
Prepaid expenses
-133,703
-154,726
-189,082
-36,168
Reduction in right-of-use asset
-
-
-
-147,016
Right-of-use asset
-
-
-109,434
-
Reduction in right-of-use asset
49,977
52,788
-
-
Accounts payable & accrued expenses
-156,687
-455,836
-565,040
1,224,786
Lease liability
-51,267
-54,001
-57,782
-129,741
Earn-out payable
-
-
0
0
Income tax payable
-175
175
-152,874
162,992
Net cash (used in) operating activities
-917,977
-2,072,100
-1,616,006
-727,800
Purchase of intangible assets
-1,895
99,389
40,998
26,103
Purchase of equipment
7,015
5,129
-1,039
8,040
Net cash (used in) investing activities
-5,120
-104,518
-50,209
-118,295
Proceeds from public offering
5,085,000
-
0
0
Exercise of warrants
2,719,185
0
724,500
0
Purchase of treasury stock
-
-
0
0
Net cash provided by financing activities
7,804,185
0
724,500
75,536
Net increase (decrease) in cash and cash equivalents
6,881,088
-2,176,618
-941,715
-770,560
Foreign currency translation adjustment
-176,642
-
-
97,165
Cash and cash equivalents at end of period
13,748,301
-
-
9,306,438
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from public
offering
$5,085,000
(178.08%↑ Y/Y)
Exercise of warrants
$2,719,185
(23.86%↑ Y/Y)
Net cash provided by
financing activities
$7,804,185
(97.66%↑ Y/Y)
Net increase
(decrease) in cash and cash...
$6,881,088
(2246.06%↑ Y/Y)
Canceled cashflow
$923,097
Inventory
-$793,996
(-170.65%↓ Y/Y)
Prepaid expenses
-$133,703
(47.68%↑ Y/Y)
Stock issued for
services
$96,900
Depreciation and
amortization
$77,974
(-43.22%↓ Y/Y)
Reduction in right-of-use
asset
$49,977
(152.94%↑ Y/Y)
Purchase of intangible
assets
-$1,895
(-100.32%↓ Y/Y)
Net cash (used in)
operating activities
-$917,977
(69.27%↑ Y/Y)
Net cash (used in)
investing activities
-$5,120
(99.23%↑ Y/Y)
Canceled cashflow
$1,152,550
Canceled cashflow
$1,895
Net (loss)
-$1,564,048
(46.99%↑ Y/Y)
Purchase of equipment
$7,015
(-95.81%↓ Y/Y)
Deposits
$209,740
Accounts payable &
accrued expenses
-$156,687
(81.56%↑ Y/Y)
Accounts receivable
$88,610
(118.00%↑ Y/Y)
Lease liability
-$51,267
(-167.87%↓ Y/Y)
Income tax payable
-$175
(98.27%↑ Y/Y)
Buy us a coffee